Quantbot Technologies’s Eidos Therapeutics EIDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-200
Closed -$26K – 1909
2020
Q4
$26K Buy
+200
New +$17.7K ﹤0.01% 977
2020
Q1
– Sell
-3,724
Closed -$213K – 1587
2019
Q4
$213K Buy
3,724
+1,132
+44% +$56K 0.02% 645
2019
Q3
$93K Buy
+2,592
New +$101K 0.01% 851

Quantbot Technologies's EIDX Position: Q1 2021 in Review

Quantbot Technologies sold out of Eidos Therapeutics (EIDX) in Q1 2021, closing a stake of 200 shares — an estimated $26K sold.

Quantbot Technologies first reported a position in EIDX in Q3 2019 and held it in 3 quarters. The position peaked at $213K in Q4 2019. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

  • Quantbot Technologies reported no remaining Eidos Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Quantbot Technologies sold 200 Eidos Therapeutics shares in Q1 2021, an estimated $26K.
  • Quantbot Technologies first reported a position in Eidos Therapeutics in Q3 2019 and held it in 3 quarters.
  • Quantbot Technologies's Eidos Therapeutics position peaked at $213K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Eidos Therapeutics as of Q1 2021.

Based on Quantbot Technologies's 13F filing for Q1 2021, filed 14 May 2021.